Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur Cell Mater ; 27: 332-49, 2014 Jun 08.
Artigo em Inglês | MEDLINE | ID: mdl-24908426

RESUMO

Open fractures are at risk of serious infection and, if infected, require several surgical interventions and courses of systemic antibiotics. We investigated a new injectable formulation that simultaneously hardens in vivo to form a porous scaffold for bone repair and delivers antibiotics at high concentrations to the local site of infection. Duration of antimicrobial activity against Staphylococcus aureus was determined using the serial plate transfer test. Ultimate compressive strength and porosity of the material was measured with and without antibiotics. The material was evaluated in vivo in an ovine medial femoral condyle defect model contaminated with S. aureus. Sheep were sacrificed at either 2 or 13 weeks and the defect and surrounding bone assessed using micro-computed tomography and histology. Antimicrobial activity in vitro persisted for 19-21 days. Sheep with antibiotic-free material and bacteria became infected, while those with antibiotic-containing material and bacteria did not. Similarly, new bone growth was seen in uninoculated animals with plain polymer, and in those with antibiotic polymer with bacteria, but not in sheep with plain polymer and bacteria. The antibiotic-impregnated scaffolds were effective in preventing S. aureus infections whilst supporting bone growth and repair. If translated into clinical practice, this approach might reduce the need for systemic antibiotics.


Assuntos
Anti-Infecciosos/farmacologia , Regeneração Óssea , Clindamicina/farmacologia , Gentamicinas/farmacologia , Osteomielite/prevenção & controle , Infecções Estafilocócicas/prevenção & controle , Alicerces Teciduais/química , Animais , Anti-Infecciosos/uso terapêutico , Plásticos Biodegradáveis/farmacologia , Clindamicina/uso terapêutico , Fêmur/microbiologia , Fêmur/cirurgia , Gentamicinas/uso terapêutico , Regeneração Tecidual Guiada/métodos , Ácido Láctico/farmacologia , Osteomielite/tratamento farmacológico , Ácido Poliglicólico/farmacologia , Copolímero de Ácido Poliláctico e Ácido Poliglicólico , Ovinos , Infecções Estafilocócicas/tratamento farmacológico , Staphylococcus aureus/efeitos dos fármacos , Staphylococcus aureus/patogenicidade
2.
Neurogenetics ; 13(1): 97-101, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22294494

RESUMO

Investigations into migraine genetics have suggested that susceptibility loci exist on the X chromosome. These reports are supported by evidence that demonstrates male probands as having a higher proportion of affected first-degree relatives as well as the female preponderance of 3:1 that the disorder displays. We have previously implicated the Xq24-28 locus in migraine using two independent multigenerational Australian pedigrees that demonstrated excess allele sharing at the Xq24, Xq27 and Xq28 loci. Here, we expand this work to investigate a further six independent migraine pedigrees using 11 microsatellite markers spanning the Xq27­28 region. Furthermore, 11 candidate genes are investigated in an Australian case-control cohort consisting of 500 cases and 500 controls. Microsatellite analysis showed evidence of excess allele sharing to the Xq27 marker DXS8043 (LOD* 1.38 P00.005) in MF879 whilst a second independent pedigree showed excess allele sharing to DXS8061 at Xq28 (LOD* 1.5 P00.004). Furthermore, analysis of these key markers in a case control cohort showed significant association to migraine in females at the DXS8043 marker (T1 P00.009) and association with MO at DXS8061 (T1 P00.05). Further analysis of 11 key genes across these regions showed significant association of a three-marker risk haplotype in the NSDHL gene at Xq28 (P00.0082). The results of this study add further support to the presence of migraine susceptibility loci on chromosome Xq27 and Xq28 as well as point to potential candidate genes in the regions that warrant further investigation.


Assuntos
Cromossomos Humanos X/genética , Predisposição Genética para Doença , Transtornos de Enxaqueca/genética , Austrália , Estudos de Casos e Controles , Feminino , Genótipo , Haplótipos , Humanos , Masculino , Repetições de Microssatélites , Linhagem , Polimorfismo de Nucleotídeo Único
3.
Cephalalgia ; 31(3): 264-70, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20813781

RESUMO

INTRODUCTION: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) shares common symptoms with migraine. Most CADASIL causative mutations occur in exons 3 and 4 of the Notch 3 gene. This study investigated the role of C381T (rs 3815188) and G684A (rs 1043994) single nucleotide polymorphisms (SNP) in exons 3 and 4, respectively, of the Notch 3 gene in migraine. RESULTS: The first part of the study, in a population of 275 migraineurs and 275 control individuals, found a significant association between the C381T variant and migraine, specifically in migraine without aura (MO) sufferers. The G684A variant was also found to be significantly associated with migraine, specifically in migraine with aura (MA) sufferers. A follow-up study in 300 migraineurs and 300 control individuals did not show replicated association of the C381T variant with migraineurs. However, the G684A variant was again shown to be significantly associated with migraine, specifically with MA. CONCLUSION: Further investigation of the G684A variant and the Notch 3 gene is warranted to understand their role in migraine.


Assuntos
Predisposição Genética para Doença , Transtornos de Enxaqueca/genética , Polimorfismo de Nucleotídeo Único , Receptores Notch/genética , Genótipo , Humanos , Reação em Cadeia da Polimerase , Receptor Notch3
4.
Hum Genet ; 124(5): 543-52, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18975005

RESUMO

To understand the underlying genetic architecture of cardiovascular disease (CVD) risk traits, we undertook a genome-wide linkage scan to identify CVD quantitative trait loci (QTLs) in 377 individuals from the Norfolk Island population. The central aim of this research focused on the utilization of a genetically and geographically isolated population of individuals from Norfolk Island for the purposes of variance component linkage analysis to identify QTLs involved in CVD risk traits. Substantial evidence supports the involvement of traits such as systolic and diastolic blood pressures, high-density lipoprotein-cholesterol, low-density lipoprotein-cholesterol, body mass index and triglycerides as important risk factors for CVD pathogenesis. In addition to the environmental influences of poor diet, reduced physical activity, increasing age, cigarette smoking and alcohol consumption, many studies have illustrated a strong involvement of genetic components in the CVD phenotype through family and twin studies. We undertook a genome scan using 400 markers spaced approximately 10 cM in 600 individuals from Norfolk Island. Genotype data was analyzed using the variance components methods of SOLAR. Our results gave a peak LOD score of 2.01 localizing to chromosome 1p36 for systolic blood pressure and replicated previously implicated loci for other CVD relevant QTLs.


Assuntos
Doenças Cardiovasculares/genética , Locos de Características Quantitativas , Adulto , Idoso , Mapeamento Cromossômico , Cromossomos Humanos Par 1/genética , Feminino , Predisposição Genética para Doença , Genética Populacional , Genótipo , Humanos , Escore Lod , Masculino , Melanesia , Pessoa de Meia-Idade , Linhagem , Fenótipo , Fatores de Risco , Caracteres Sexuais
5.
Heredity (Edinb) ; 100(4): 366-73, 2008 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-18091769

RESUMO

Norfolk Island is a human genetic isolate, possessing unique population characteristics that could be utilized for complex disease gene localization. Our intention was to evaluate the extent and strength of linkage disequilibrium (LD) in the Norfolk isolate by investigating markers within Xq13.3 and the NOS2A gene encoding the inducible nitric oxide synthase. A total of six microsatellite markers spanning approximately 11 Mb were assessed on chromosome Xq13.3 in a group of 56 men from Norfolk Island. Additionally, three single nucleotide polymorphisms (SNPs) localizing to the NOS2A gene were analyzed in a subset of the complex Norfolk pedigree. With the exception of two of the marker pairs, one of which is the most distantly spaced marker, all the Xq13.3 marker pairs were found to be in significant LD indicating that LD extends up to 9.5-11.5 Mb in the Norfolk Island population. Also, all SNPs studied showed significant LD in both Norfolk Islanders and Australian Caucasians, with two of the marker pairs in complete LD in the Norfolk population only. The Norfolk Island study population possesses a unique set of characteristics including founder effect, geographical isolation, exhaustive genealogical information and phenotypic data of use to cardiovascular disease risk traits. With LD extending up to 9.5-11 Mb, the Norfolk isolate should be a powerful resource for the localization of complex disease genes.


Assuntos
Cromossomos Humanos X/genética , Desequilíbrio de Ligação , Feminino , Efeito Fundador , Humanos , Masculino , Repetições de Microssatélites , Óxido Nítrico Sintase Tipo II/genética , Ilhas do Pacífico , Linhagem , Polimorfismo de Nucleotídeo Único , Grupos Raciais/genética
6.
Br J Cancer ; 75(11): 1567-74, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9184170

RESUMO

The level of expression of keratinocyte growth factor (KGF) mRNA has been measured in human breast cell lines, purified populations of epithelial cells, myoepithelial cells and fibroblasts from reduction mammoplasty tissue and a panel of 42 breast cancers and 30 non-malignant human breast tissues using a semiquantitative reverse transcriptase polymerase chain reaction (RT-PCR) procedure. We found similar levels of KGF mRNA in malignant and non-malignant breast tissues. The study of the amount of KGF mRNA in breast cell lines and purified populations of cells revealed that fibroblasts are the predominant source of KGF with malignant and non-malignant epithelial cells containing very low levels of KGF mRNA. We have examined the distribution of fibroblast growth factor receptor (FGFR)-2-IIIb, which is a high-affinity receptor for KGF and find that it is present on malignant and non-malignant epithelial cells. The level of FGFR-2-IIIb present on breast cancer cell lines was sufficient for KGF stimulation of breast cancer cell proliferation. Other members of the fibroblast growth factor family have been either not expressed in the human breast (FGF3, FGF4) or have been found at much reduced levels in breast cancer (FGF1, FGF2) and this is the first member of the family to potentially influence the progression of breast cancer through stimulation of cell division.


Assuntos
Neoplasias da Mama/química , Fatores de Crescimento de Fibroblastos , Substâncias de Crescimento/análise , Receptores de Fatores de Crescimento/análise , Mama/química , Divisão Celular/efeitos dos fármacos , Feminino , Fator 10 de Crescimento de Fibroblastos , Fator 7 de Crescimento de Fibroblastos , Substâncias de Crescimento/genética , Humanos , RNA Mensageiro/análise , Receptor Tipo 2 de Fator de Crescimento de Fibroblastos , Receptores de Fatores de Crescimento de Fibroblastos/análise , Células Tumorais Cultivadas
7.
J Biol Chem ; 270(51): 30643-50, 1995 Dec 22.
Artigo em Inglês | MEDLINE | ID: mdl-8530501

RESUMO

We have raised specific antibodies to the second immunoglobulin-like domain of fibroblast growth factor receptors (FGFRs) and used these to investigate the expression and subcellular localization of FGFR-1, -2, -3, and -4 in breast epithelial cells. All four receptors classes could be detected in breast cell lines; however, FGFR-4 and FGFR-2 appeared to be expressed at a higher level in breast cancer cell lines than in normal epithelial cells. Surprisingly, FGFR-3 localized in the cell nucleus by immunofluorescence. A second antibody to a separate epitope confirmed this finding and showed that the form of FGFR-3 present must contain an intact kinase domain as well as the growth factor binding domain. Western analysis of fractionated cells revealed the presence of two forms of FGFR-3 of 135 and 110 kDa. The 110-kDa form was predominantly found in the nucleus, whereas the 135 kDa form was sometimes found in the nucleus. RT-PCR analysis of FGFR-3 mRNA showed the presence of a splice variant in which exons 7 and 8 are deleted. This results in the translation of FGFR-3 missing the transmembrane domain but with an intact kinase domain, which could be a soluble, intracellular receptor. Transfection experiments showed that FGFR-3 containing this deletion and no signal peptide gave an identical nuclear staining pattern to that seen in breast epithelial cells. We conclude that two forms of FGFR-3 are present in breast epithelial cells; a full-length 135-kDa receptor, which has a conventional membrane localization, and a novel soluble form of 110 kDa.


Assuntos
Processamento Alternativo , Núcleo Celular/metabolismo , Proteínas Tirosina Quinases , Receptores de Fatores de Crescimento de Fibroblastos/metabolismo , Sequência de Aminoácidos , Animais , Sequência de Bases , Mama/metabolismo , Neoplasias da Mama/metabolismo , Linhagem Celular , Chlorocebus aethiops , Códon , Primers do DNA , Epitélio/metabolismo , Éxons , Feminino , Fatores de Crescimento de Fibroblastos/metabolismo , Imunofluorescência , Variação Genética , Humanos , Soros Imunes , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Estrutura Secundária de Proteína , Receptores Proteína Tirosina Quinases/análise , Receptores Proteína Tirosina Quinases/biossíntese , Receptores Proteína Tirosina Quinases/metabolismo , Receptor Tipo 1 de Fator de Crescimento de Fibroblastos , Receptor Tipo 2 de Fator de Crescimento de Fibroblastos , Receptor Tipo 3 de Fator de Crescimento de Fibroblastos , Receptor Tipo 4 de Fator de Crescimento de Fibroblastos , Receptores de Fatores de Crescimento de Fibroblastos/análise , Receptores de Fatores de Crescimento de Fibroblastos/biossíntese , Proteínas Recombinantes/análise , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/metabolismo , Deleção de Sequência , Transfecção , Células Tumorais Cultivadas
8.
Biochem J ; 306 ( Pt 2): 609-16, 1995 Mar 01.
Artigo em Inglês | MEDLINE | ID: mdl-7534069

RESUMO

Acidic and basic fibroblast growth factors (aFGF and bFGF) are growth factors which may have a physiological role in the normal breast and in breast cancer. A study of the effects of aFGF and bFGF on a variety of breast cell lines and epithelial cells purified from normal breast organoids showed that whereas normal breast cells did not exhibit membrane ruffling in response to either of these growth factors, some breast cancer cell lines did. This difference was not due to lack of receptor since all the cell lines tested were mitogenically stimulated by bFGF. Dominant negative mutations of FGF receptor 3 (FGFR-3) and the small GTP-binding protein p21rac inhibited membrane ruffling, showing that receptor dimerization and phosphorylation and p21rac activation are prerequisites for membrane ruffling in response to aFGF and bFGF. Transient transfection of individual FGFRs into cos-7 cells showed that FGFR-1, FGFR-2 and FGFR-3 could not mediate a membrane ruffling response whereas FGFR-4 could. These studies elucidate one signalling mechanism of FGF and point to differences in the response of normal and cancer breast epithelial cells which may be important in cell motility.


Assuntos
Neoplasias da Mama/ultraestrutura , Mama/ultraestrutura , Membrana Celular/patologia , Fator 1 de Crescimento de Fibroblastos/farmacologia , Fator 2 de Crescimento de Fibroblastos/farmacologia , Proteínas Tirosina Quinases , Receptores de Fatores de Crescimento de Fibroblastos/fisiologia , Células 3T3/ultraestrutura , Animais , Epitélio/ultraestrutura , Proteínas de Ligação ao GTP/genética , Proteínas de Ligação ao GTP/fisiologia , Humanos , Camundongos , Microscopia de Fluorescência , Mutagênese Sítio-Dirigida , Receptor Tipo 3 de Fator de Crescimento de Fibroblastos , Receptor Tipo 4 de Fator de Crescimento de Fibroblastos , Receptores de Fatores de Crescimento de Fibroblastos/genética , Transfecção , Proteínas rac de Ligação ao GTP
9.
Todays OR Nurse ; 16(1): 38-40, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-8116024

RESUMO

1. Verbal abuse, defined as "communication that is perceived to be a harsh, condemnatory attack towards the victim, either professionally or personally," most commonly follows a stressful event. 2. Verbal abuse has multiple areas of negative impact on nursing practice, including increased numbers of errors and, subsequently, lawsuits. 3. Verbal abuse is costly. There is no valid reason to allow verbal abuse to continue because it can be successfully controlled.


Assuntos
Agressão , Comunicação , Relações Interprofissionais , Recursos Humanos de Enfermagem Hospitalar , Recursos Humanos em Hospital , Humanos , Fala
10.
J Contin Educ Nurs ; 22(4): 159-62, 1991.
Artigo em Inglês | MEDLINE | ID: mdl-1906482

RESUMO

In producing quality continuing education courses, contracting with and establishing rapport with speakers is as important as marketing the course itself. Presented in this article are four phases of working with speakers: initial phase, midpoint phase, course presentation phase, and post-course phase. Not only do these phases assist the continuing education program staff in developing a highly organized and well-planned program, but also they offer numerous benefits to speakers so that they can feel comfortable with all arrangements. Thus, the learning atmosphere is one in which the speaker can relax and fully enjoy the continuing education experience.


Assuntos
Serviços Contratados/normas , Educação Continuada em Enfermagem/métodos , Ensino/métodos , Publicidade , Serviços Contratados/economia , Análise Custo-Benefício , Educação Continuada em Enfermagem/economia , Educação Continuada em Enfermagem/normas , Humanos , Ensino/economia , Ensino/normas
15.
Int Arch Allergy Appl Immunol ; 56(2): 123-7, 1978.
Artigo em Inglês | MEDLINE | ID: mdl-563850

RESUMO

When human serum was passed through a column of insolubilised protein A, IgE was not removed, but IgG sublasses 1,2 and 4 were retained. Protein A did not show a similar selectivity in its interaction with rat immunoglobulins. The separation of human IgE from the bulk of the IgG was used to examine the effect of IgG on IgE-mediated sensitization of lung tissue for histamine reslease. Removal of IgG led to a significant increase in histamine release, suggesting that homocytotropic IgG competes with IgE, for binding sites on mast cells.


Assuntos
Imunoglobulina E/isolamento & purificação , Imunoglobulina G/isolamento & purificação , Animais , Cromatografia de Afinidade , Humanos , Ratos , Proteína Estafilocócica A
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA